Asia’s biopharma industry is growing, and growing fast. With technical expertise, low manufacturing costs and improving regulatory frameworks, its value will soon run into the hundreds of billions of dollars. Are you making the most of the opportunity?
Welcome to BioPharma Asia 2016. From humble beginnings as BioMedical Asia in 2008, BioPharma Asia has attracted close to 20,000 attendees over the last 8 years. Established as
a true one-stop shop for all things biopharma, our 2016 program will be bigger than ever before, offering you more tracks, more content and more value. Our 7 premium conference tracks will explore innovation in clinical trials, manufacturing, supply chain, market access, partnering, pricing, vaccines and infectious diseases, antibodies, orphan drugs, biosimilars, stem cells and more.
Our keynote presenters have already confirmed for 2016 and include:
Jun Wang, Founder, Executive Director
Beijing Genome Institute (BGI), China
Executive Director – Biomedical Sciences, Singapore Economic Development Board
Niven R. Narain
Co-Founder, President and Chief Technology Officer, BERG Pharma
Prof Zelig Eshhar
Chairman, Department of Immunology
Weizmann Institute of Science, Israel
Chief Scientific Officer
ASLAN Pharma, Singapore
Nanyang Assistant Professor
NRF Fellow, Nanyang Technology University, Singapore
Korea Polytechnic University, Korea
Plus we have confirmed over 50 speakers from the following pharmaceutical companies such as:
Janssen | Roche | Eli Lilly | Baxalta | Sphaera Pharma | GSK | Sanofi | Eisai | Berg Pharma | Novartis | ASLAN Pharma | Astra Zeneca | Pfizer | Johnson and Johnson | Merck | PharmAbcine | Roche | Yisheng Biopharma | Global BioPharma (GBP) | AbbVie | MSD | Daiichi-Sankyo | Imugene | Seattle Genetics
And more. Go to www.terrapinn.com/bioasia now! Tiered early bird offers available. Book early and save more!
Event Promotion by @evvnt - http://bit.ly/septPROMOTE